Novartis discontinues development of GT005 for geographic atrophy healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
(Reuters) - British healthcare investment firm Syncona said on Monday Novartis has stopped the development of experimental eye treatment, GT005, which .
Britain s FTSE 100 index is
seen opening higher on Monday, with futures up 0.34%. VISTRY: British homebuilder Vistry Group said it
would merge its affordable-housing.
(Reuters) - British healthcare investment firm Syncona said on Monday Novartis has stopped the development of experimental eye treatment, GT005, which.